Login
$MGNX
$2.14 -$0.03 (1.38%) After hours

Company Executives

Officer Age In this role Joined 2025 pay Source
Eric Risser Also a director
President, Chief Executive Officer and Director
53 Not stated 2009 $2,078,854
James Karrels
Senior Vice President and Chief Financial Officer
59 Not stated 2008 $1,149,232
Jeffrey Peters
Senior Vice President, General Counsel, Corporate Compliance Officer and Corporate Secretary
55 Not stated 2015 Not reported
Ezio Bonvini
Sr VP, Research & CSO
Title from the Form 4 dated Oct 6, 2026
72 Not stated 2003 $1,224,038
Thomas Spitznagel
Senior Vice President, Technical Operations
59 Not stated 2013 Not reported
Beth Smith
Vice President, Controller and Treasurer
58 Since 2024
2 years
2013 Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

From the proxy statement filed Apr 8, 2026 · updated by the 8-Ks of Jul 8, 2026 and Nov 3, 2026

Directors
12
serving now
Independent
2 of 4
stated in the proxy; 8 not stated
Average tenure
11.1 years
from year joined
CEO also chairs the board
No
William Heiden
Director Age On board Independent Committees Other public boards 2025 pay Source
William Heiden
66 Not stated Not stated None stated Atara Biotherapeutics, Inc. $145,030
Eric Risser
53 Not stated Not independent None stated None stated Paid as CEO
Scott Koenig
73 2001
25 years
Not independent None stated None stated Not stated
Federica O'Brien
68 2021
5 years
Not stated None stated TELA Bio, Inc. $110,477
Scott Jackson
61 2017
9 years
Not stated None stated Spero Therapeutics, Inc. $81,905
Margaret A. Liu
69 2023
3 years
Not stated None stated Ipsen $85,863
David Stump
76 2013
13 years
Not stated None stated REGENXBIO, Inc. $95,863
Edward Hurwitz
62 2004
22 years
Not stated None stated Dyne Therapeutics $85,863
Meenu Chhabra Karson
53 2023
3 years
Not stated None stated None stated $80,217
Michael Vasconcelles Joined Oct 30, 2026
- - Independent
Science and Technology Committee
- -
Emil Kuriakose Joined Oct 30, 2026
- - Independent
Science and Technology Committee
- -
Jay Siegel Leaving at the meeting
73 2017
9 years
Not stated None stated None stated $106,280

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive. A director marked Joined was added by an 8-K; their row opens that 8-K, and a dash is a value it does not give.

No related-party transactions disclosed

The proxy filed Apr 8, 2026 states there were none.

Read it in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support